Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
National and Subnational Burden of Stroke in Iran From 1990 to 2019 Publisher Pubmed



Fallahzadeh A1 ; Esfahani Z1, 2 ; Sheikhy A1 ; Keykhaei M1, 3 ; Moghaddam SS1 ; Tehrani YS1 ; Rezaei N1, 4 ; Ghasemi E1 ; Azadnajafabad S1 ; Mohammadi E1 ; Koolaji S1 ; Shahin S1 ; Rezaei N1, 4 ; Larijani B4 Show All Authors
Authors
  1. Fallahzadeh A1
  2. Esfahani Z1, 2
  3. Sheikhy A1
  4. Keykhaei M1, 3
  5. Moghaddam SS1
  6. Tehrani YS1
  7. Rezaei N1, 4
  8. Ghasemi E1
  9. Azadnajafabad S1
  10. Mohammadi E1
  11. Koolaji S1
  12. Shahin S1
  13. Rezaei N1, 4
  14. Larijani B4
  15. Farzadfar F1, 4
Show Affiliations
Authors Affiliations
  1. 1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  3. 3. Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, 60611, IL, United States
  4. 4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Annals of Clinical and Translational Neurology Published:2022


Abstract

Background: Data on the burden of stroke and changing trends at national and subnational levels are necessary for policymakers to allocate recourses appropriately. This study presents estimates of the stroke burden from 1990 to 2019 using the results of the Global Burden of Disease (GBD) 2019 study. Methods: For the GBD 2019, verbal autopsy and vital registration data were used to estimate stroke mortality. Cause-specific mortality served as the basis for estimating incidence, prevalence, and disability-adjusted life years (DALYs). The burden attributable to stroke risk factors was calculated by a comparative risk assessment. Decomposition analysis was applied to determine the contribution of population aging, population growth, and changes in the age-specific incidence rates. Results: In 2019, the number of prevalent cases, incident cases, and deaths due to stroke in Iran were 963,512; 102,778; and 40,912, respectively. The age-standardized incidence rate (ASIR) and the age-standardized death rate (ASDR) decreased from 1990 to 2019. Of national stroke ASDRs in 2019, 44.7% (35.7–54.7%) were attributable to hypertension and 28.8% (15.2–57.4) to high fasting plasma glucose. At the subnational level, the trend of the stroke incidence and mortality rate decreased in all provinces. Stroke was responsible for 4.48% of total DALYs in 2019 (3.38% due to ischemic stroke, 0.87% due to intracerebral hemorrhage, and 0.22% due to subarachnoid hemorrhage). Conclusion: ASIR and ASDR of stroke are decreasing nationally and subnationally; however, the number of incident cases and deaths are increasing in all SDI quintiles, possibly due to population growth. © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Experts (# of related papers)
Other Related Docs
31. Incidence, Early Case Fatality and Determinants of Stroke in Iran: Golestan Cohort Study, Journal of Stroke and Cerebrovascular Diseases (2022)